General Information of the Compound
Compound ID
CP0453357
Compound Name
2-((R)-2-Methyl-4-pyridin-2-yl-piperazin-1-ylmethyl)-1H-benzoimidazole
    Show/Hide
Structure
Formula
C18H21N5
Molecular Weight
307.401
Canonical SMILES
C[C@@H]1CN(CCN1Cc1nc2ccccc2[nH]1)c1ccccn1
    Show/Hide
InChI
InChI=1S/C18H21N5/c1-14-12-23(18-8-4-5-9-19-18)11-10-22(14)13-17-20-15-6-2-3-7-16(15)21-17/h2-9,14H,10-13H2,1H3,(H,20,21)/t14-/m1/s1
    Show/Hide
InChIKey
NFCYVMDRDOBUCA-CQSZACIVSA-N
Physicochemical Property
logP
2.6686
Rotatable Bonds
3
Heavy Atom Count
23
Polar Areas
48.05
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9836209
SID: 14796462
ChEMBL ID
CHEMBL126529
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01161, D(4) dopamine receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 64 nM
   TI
   LI
   LO
   TS